14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $137.78 $156.84 Tuesday, 23rd Apr 2024 ASND stock ended at $144.83. This is 1.92% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 2.90% from a day low at $143.30 to a day high of $147.45.
90 days $128.67 $161.00
52 weeks $66.03 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
Feb 09, 2024 $140.27 $143.48 $139.84 $141.75 388 326
Feb 08, 2024 $140.82 $143.90 $137.02 $139.25 485 204
Feb 07, 2024 $141.94 $142.16 $138.91 $139.29 653 969
Feb 06, 2024 $143.64 $144.95 $140.27 $140.84 359 766
Feb 05, 2024 $139.77 $143.54 $136.79 $143.09 466 556
Feb 02, 2024 $139.43 $143.76 $139.40 $139.77 416 855
Feb 01, 2024 $130.60 $141.75 $129.25 $141.63 602 562
Jan 31, 2024 $129.16 $132.73 $128.67 $129.93 629 068
Jan 30, 2024 $133.53 $133.53 $129.16 $129.20 289 870
Jan 29, 2024 $132.61 $135.35 $131.38 $134.39 175 760
Jan 26, 2024 $132.10 $134.65 $131.00 $132.46 369 311
Jan 25, 2024 $135.09 $135.20 $131.01 $131.75 270 767
Jan 24, 2024 $137.28 $137.56 $133.77 $134.12 233 813
Jan 23, 2024 $134.63 $137.03 $132.36 $136.50 317 641
Jan 22, 2024 $131.80 $135.58 $131.25 $134.16 325 898
Jan 19, 2024 $132.86 $133.00 $130.26 $132.02 268 868
Jan 18, 2024 $132.61 $133.98 $129.55 $132.98 387 714
Jan 17, 2024 $132.16 $133.71 $130.72 $132.40 916 881
Jan 16, 2024 $130.85 $134.15 $128.68 $133.50 546 049
Jan 12, 2024 $135.82 $138.50 $131.01 $131.23 358 126
Jan 11, 2024 $136.85 $138.10 $134.61 $135.43 203 324
Jan 10, 2024 $137.16 $138.38 $135.56 $136.90 313 296
Jan 09, 2024 $138.24 $140.00 $135.48 $137.10 360 943
Jan 08, 2024 $131.00 $139.06 $127.70 $138.24 447 673
Jan 05, 2024 $122.60 $130.47 $119.03 $129.72 353 012
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT